Last update :
01/07/2022
Sympathomimetic   Epinephrine hydrochloride  
Injection
Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adrenalin Canada, Denmark, Finland, Germany, Iceland, Luxembourg, Norway, Spain, Sweden, Switzerland, Turkey
Adrenalina Argentina, Colombia, Portugal, Romania, Spain
Adrenaline Egypt, France, New Zealand, Saudi Arabia
Anapen Austria, France, Great Britain, Netherlands, Sweden, Switzerland
Emerade Germany, Romania
Epipen Canada, Denmark, Finland, Great Britain, Netherlands, New Zealand, Norway, Sweden, Switzerland, United States of America
L - Adrenalin Austria
Levophed Greece
Levopress Venezuela
Min I Ject Adrenalin Great Britain
Pinadrina Mexico
Suprarenin Austria, Germany
Tonogen Hungary
Vasocon India
Stability in solutions   Injection   Stability in solutions : Epinephrine hydrochloride     
Container Solvent Concentration Temperature Storage Length of time References
Glass Water for Injection 100 µg/ml 25°C Protect from light
7 Day
659

Glass Water for Injection 100 µg/ml 25°C Protect from light
7 Day
659

Glass Water for Injection 700 µg/ml 25°C Protect from light
56 Day
659

Glass Water for Injection 700 µg/ml 25°C Protect from light
56 Day
659

Polyvinyl chloride Sodium chloride 0,9% 16 µg/ml 23-25°C Light
45 Day
4026
Level of evidence D

Polyvinyl chloride Sodium chloride 0,9% 16 µg/ml 3-5°C Protect from light
60 Day
4026
Level of evidence D

Polyvinyl chloride Sodium chloride 0,9% 64 µg/ml 23-25°C Light
45 Day
4026
Level of evidence D

Polyvinyl chloride Sodium chloride 0,9% 64 µg/ml 3-5°C Protect from light
60 Day
4026
Level of evidence D

Polyvinyl chloride Glucose 5% 100 µg/ml 23°C Protect from light
24 Hour
192

Polyvinyl chloride Glucose 5% 16 µg/ml 5°C Protect from light
20 Day
197

Not specified Glucose 5% 100 µg/ml 25°C Protect from light
30 Day
3704
Level of evidence C

Not specified Glucose 5% 100 µg/ml 4°C Protect from light
30 Day
3704
Level of evidence C

Not specified Glucose 5% 25 µg/ml 25°C Protect from light
30 Day
3704
Level of evidence C

Not specified Glucose 5% 25 µg/ml 4°C Protect from light
30 Day
3704
Level of evidence C

Not specified Glucose 5% 50 µg/ml 25°C Protect from light
30 Day
3704
Level of evidence C

Not specified Glucose 5% 50 µg/ml 4°C Protect from light
30 Day
3704
Level of evidence C

Syringe polycarbonate Water for Injection 100 µg/ml 2-8°C Protect from light
172 Day
3309

Polypropylen Syringe Water for Injection 100 µg/ml 25°C Protect from light
7 Day
659

Polypropylen Syringe Water for Injection 700 µg/ml 25°C Protect from light
56 Day
659

Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D

Polypropylen Syringe NaCl 0,9% or Glucose 5% 300 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D

Polypropylen Syringe NaCl 0,9% or Glucose 5% 900 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D

Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 2-8°C Protect from light
90 Day
4323

Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 25°C Not specified
21 Day
4393
Level of evidence D

Conflicting data
Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 4°C Not specified
56 Day
4393
Level of evidence D

Conflicting data
Polypropylen Syringe Glucose 5% 20 µg/ml 2-8°C Protect from light
183 Day
3445
Level of evidence B

Polypropylen Syringe Glucose 5% 20 µg/ml 2-8°C Protect from light
180 Day
3397

Polypropylen Syringe None 1000 µg/ml 38°C With or without light
60 Day
2579

Polypropylen Syringe Glucose 10% 20 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D

Polypropylen Syringe Glucose 10% 300 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D

Polypropylen Syringe Glucose 10% 900 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D


  Mentions Légales